Pirenperone

Pirenperone

SCHEMBL10967003

Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1.O=P(O)(O)O

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Pirenperone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A known ✓ P35348 4/20 0.48
HRH1 known ✓ P35367 2/20 0.48
ADRB2 known ✓ P07550 1/20 0.48
ADRA1B known ✓ P35368 1/20 0.48
OPRM1 known ✓ P35372 1/20 0.48
OPRK1 known ✓ P41145 1/20 0.48
HTR2C P28335 6/20 0.93
CYP2D6 P10635 4/20 0.93
MAPT P10636 3/20 0.93
TSHR P16473 3/20 0.93
KDM4E B2RXH2 3/20 0.93
CYP3A4 P08684 3/20 0.93
HTR1A P08908 3/20 0.93
MEN1 O00255 2/20 0.93
PKM P14618 2/20 0.93
PMP22 Q01453 2/20 0.93
KMT2A Q03164 2/20 0.93
SMN1; SMN2 Q16637 2/20 0.93
HPGD P15428 1/20 0.93
THPO P40225 1/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pirenperone SCHEMBL467209 0.96 HTR2C (1.00) HTR2CCYP2D6MAPTTSHRKDM4E
Pirenperone SCHEMBL10965711 0.96 HTR2C (0.98) HTR2CCYP2D6MAPTTSHRKDM4E
Pirenperone SCHEMBL10970070 0.93 HTR2C (0.93) HTR2CCYP2D6MAPTTSHRKDM4E
Pirenperone SCHEMBL11242425 0.91 CYP2D6 (0.89) HTR2CCYP2D6MAPTTSHRKDM4E
SCHEMBL17532707 0.89 CYP2D6 (0.86) HTR2CCYP2D6MAPTTSHRKDM4E
SCHEMBL10967011 0.89 CYP2D6 (0.86) HTR2CCYP2D6MAPTTSHRKDM4E
SCHEMBL6527939 0.84 HTR2C (0.77) HTR2CCYP2D6MAPTTSHRKDM4E
Metrenperone SCHEMBL2109868 0.84 HTR2C (0.77) HTR2CCYP2D6MAPTTSHRKDM4E
SCHEMBL6522324 0.83 HTR2C (0.76) HTR2CCYP2D6MAPTTSHRKDM4E
SCHEMBL10963572 0.83 CYP2D6 (0.75) HTR2CCYP2D6MAPTTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0037265-B1 3-(1-PIPERIDINYLALKYL)-4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1985-01-23 EP disclosed
US-4342870-A SEROTONIN ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1982-08-03 US disclosed
EP-0037265-A1 3-(1-piperidinylalkyl)-4H-pyrido(1,2-a)pyrimidin-4-one derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1981-10-07 EP disclosed